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Elk-1 modulatEs gEnE transcription
Elk-1 bElongs to thE Ets family of tErnary complEx factors
Elk-1 is a member of the Ets (E twenty-six) oncogene family of tran-
scription factors that includes nuclear phosphoproteins involved 
in many biological processes, such as cell growth, differentiation 
and survival, hematopoiesis, angiogenesis, wound healing, cancer, 
and inflammation (Sharrocks, 2001).
The Ets transcription factor family is defined by the presence of a 
highly conserved DNA-binding domain (DBD, the Ets domain) com-
prised of 85 amino acids. This family can be divided into subfamilies 
according to the homology of their Ets domain (Laudet et al., 1999), 
and comprises at least 27 different transcription factors in mammals. 
Two-thirds are expressed in most adult tissues, albeit with different 
levels of expression (Hollenhorst et al., 2004). A chromatin immuno-
precipitation coupled with genome wide promoter microarrays was 
used to uncover the mechanisms regulating specificity within the Ets 
family (Hollenhorst et al., 2007). Frequent redundant occupancy was 
detected that correlated with housekeeping classes of genes, whereas 
specific binding examples represented more specialized genes.
Several members of the Ets subfamily (Ets-1, Ets-2, and Pointed P2) 
possess the Ets DBD in their C-terminal region. In the case of the TCF 
subfamily this motif is located in the N-terminus end of the protein.
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The ternary complex factor (TCF) Elk-1 is a transcription factor that regulates immediate early 
gene (IEG) expression via the serum response element (SRE) DNA consensus site. Elk-1 is 
associated with a dimer of serum response factor (SRF) at the SRE site, and its phosphorylation 
occurs at specific residues in response to mitogen-activated protein kinases (MAPKs), including 
c-Jun-N terminal kinase (JNK), p38/MAPK, and extracellular-signal regulated kinase (ERK). This 
phosphorylation event is critical for triggering SRE-dependent transcription. Although MAPKs are 
fundamental actors for the instatement and maintenance of memory, and much investigation 
of their downstream signaling partners have been conducted, no data yet clearly implicate 
Elk-1 in these processes. This is partly due to the complexity of Elk-1 sub-cellular localization, 
and hence functions, within neurons. Elk-1 is present in its resting state in the cytoplasm, 
where it colocalizes with mitochondrial proteins or microtubules. In this particular sub-cellular 
compartment, overexpression of Elk-1 is toxic for neuronal cells. When phosphorylated by the 
MAPK/ERK, Elk-1 translocates to the nucleus where it is implicated in regulating chromatin 
remodeling, SRE-dependent transcription, and neuronal differentiation. Another post-translational 
modification is the conjugation to SUMO (Small Ubiquitin-like MOdifier), which relocalizes Elk-1 
in the cytoplasm. Thus, Elk-1 plays a dual role in neuronal functions: pro-apoptotic within the 
cytoplasm, and pro-differentiation within the nucleus. To address the role of Elk-1 in the brain, 
one must be aware of its multiple facets, and design molecular tools that will shut down Elk-1 
expression, trafficking, or activation, in specific neuronal compartments. We summarize in this 
review the known molecular functions of Elk-1, its regulation in neuronal cells, and present 
evidence of its possible implication in model systems of synaptic plasticity, learning, but also 
in neurodegenerative diseases.
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Originally described in HeLa cell nuclear extracts, TCFs form a 
ternary complex with two molecules of SRF on the consensus DNA 
binding region called SRE at the c-fos promoter (Herrera et al., 1989; 
Shaw et al., 1989). First called p62 due to its 62000 Da molecular 
weight (Shaw et al., 1989), it was then shown to be homologous to 
Elk-1 (Ets-like transcription factor) that had been cloned previously 
(Rao et al., 1989; Hipskind et al., 1991). Two other related cDNAs 
were also identified, Sap-1 (SRF accessory protein 1)/Elk-4 (Dalton 
and Treisman, 1992) and Net/Erp/Sap-2/Elk-3 (Giovane et al., 1994; 
Lopez et al., 1994; Nozaki et al., 1996). The three TCFs, Net, Elk-1, 
and Sap-1 are distinct gene products with different chromosomal 
localizations in both the mouse and human genomes (Giovane 
et al., 1995).
Each of the TCFs contains four conserved domains with high 
sequence and functional similarities, named A-D (Figure 1). The 
A domain, localized in the N-terminal region, corresponds to the 
Ets DBD. This motif contains a nuclear localization signal (NLS) 
as well as a nuclear export signal (NES) that is deleted in a smaller, 
neuronal, isoform of Elk-1 called short-Elk-1 (sElk-1; Vanhoutte 
et al., 2001). The B box domain, which enables TCFs to interact 
co-operatively with SRF and promotes ternary complex formation, 
is located downstream of the Ets domain (Treisman et al., 1992; 
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Serum response elements are also located in the promoters of 
other IEGs, such as junB, egr-1 (early growth response gene-1, also 
called zif268 or NGF-IA), and Nur77, the murine homolog of the 
human NR4A1 gene (Treisman et al., 1992). The recent identifica-
tion of the repertoire of Elk-1 target genes reveals that a significant 
number of them encode transcription factors but also components 
of the basal transcriptional machinery, such as the TATA bind-
ing protein (TBP; Boros et al., 2009a). Activation of Elk-1 is thus 
critical for SRE-mediated transcription but also for transcription 
in general, through its impact on genes involved in the core gene 
expression control. Interestingly, the srf gene itself has been identi-
fied as an Elk-1 target (Kasza et al., 2005).
transcriptional activity inducEd by Elk-1 phosphorylation
The transcriptional activity of Elk-1 depends on its phosphorylation, 
which is regulated by the MAP kinase pathway. Elk-1 is activated 
through phosphorylation by the three classes of MAP kinases, ERK, 
JNK, and p38 (Cavigelli et al., 1995; Gille et al., 1995; Whitmarsh 
et al., 1995; Enslen et al., 1998; Cruzalegui et al., 1999). While the ERK 
cascade is activated by growth factors and mitogens, the JNK and p38 
cascades respond to cytokines and stress. Phosphorylation by MAP 
kinases can occur on at least nine residues in the C domain of Elk-1 
(Cruzalegui et al., 1999), two of them, Serine 383 and Serine 389, 
being crucial for the transcriptional activity of Elk-1. Once mutated 
in non-phosphorylable alanines, SRE-dependent gene induction by 
Elk-1 is totally blocked (Janknecht et al., 1993). Moreover, the Serine 
383 is particularly important for the transactivating properties of 
Elk-1, because a single mutation of this residue evokes a total loss 
of these properties (Gille et al., 1995). In Elk-1, the DEF motif is 
responsible for direct ERK-induced phosphorylation of this residue. 
At the molecular level, the C-terminal phosphorylation of Elk-1 
leads to a conformational change in the overall tertiary structure 
of Elk-1 (Yang et al., 1999). This, in turn, results in an increased 
binding to SRF via the B box, and overall increased DNA binding 
of Elk-1 to the 5′CAGGA motif of the SRE.
Once activated by phosphorylation, Elk-1 promotes, in addition 
to enhanced DNA binding to the SRE, a recruitment of coacti-
vators, including CREB binding protein (CBP), p300, or the Srb 
Hill et al., 1993). The D domain contains the DEJL (docking site 
for ERK and JNK LXL) consensus sequence that permits the bind-
ing to MAP kinases of ERK, JNK, and p38MAPK families. The 
C-terminal end of the protein corresponds to the transcriptional 
activation domain, or C domain, containing the multiple S/TP 
motifs targeted by activated MAP kinases (Marais et al., 1993; 
Janknecht et al., 1994). Within this region lies a docking domain, 
the FXFP or DEF (docking site for ERK FXFP) motif, which is 
specifically involved in docking to ERK (Sharrocks et al., 2000; 
Fantz et al., 2001). In Elk-1, the DEF domain is critically required 
for its selective phosphorylation by the MAPK kinase/ERK (Jacobs 
et al., 1999).
Two variants of Elk-1 have been described so far, ∆Elk-1 and 
sElk-1. ∆Elk-1 is an alternative splicing variant lacking the SRF 
interaction domain and a part of the Elk-1 DBD (Rao and Reddy, 
1993). sElk-1 is a neuronal specific isoform of Elk-1 that arises from 
an internal translation start site in its sequence, and corresponds to 
a protein lacking the first 54 amino acids of the DBD (Vanhoutte 
et al., 2001). Thus, both truncated proteins present different DNA 
binding properties than full-length protein.
classEs of gEnEs targEtEd by Elk-1
The best-characterized Elk-1 target is the proto-oncogene c-fos 
(Hipskind et al., 1991; Gille et al., 1992; Hill et al., 1993). Its pro-
moter is regulated rapidly and transiently by mitogens via the SRE 
(Treisman et al., 1992), which binds the ternary complex formed 
by two molecules of SRF and one of the TCFs (Hill et al., 1993). 
Inhibiting formation or activity of this ternary complex leads to 
down-regulation of c-fos expression induced by serum. Conversely, 
increasing the activity of the ternary complex, through phosphor-
ylation of TCFs, increases transcription. The recruitment of Elk-1 
to SRE is made by a combination of protein–protein and protein–
DNA interactions, via its Ets domain and B box, respectively. The 
determinant residues in SRF–Elk1 interaction are Tyrosine 153, 
Tyrosine 159, and Phenylalanine 162 (Ling et al., 1998). These resi-
dues represent a large fraction of Elk-1’s surface interaction with 
SRF and increase the intrinsic binding activity of Elk-1 toward 
SRE sites.
FiguRE 1 | Diagram illustrating functional domains and major post-
translational modifications of the Elk-1 protein. The ETS domain (or A) 
domain lies within the n-terminus end of the protein and is responsible for Elk-1 
binding to DNA. The B domain is involved in the binding of Elk-1 to a dimer of its 
cofactor, the SRF . The R domain is crucial for the repression of Elk-1 
transcriptional activity. It contains the lysine residues that are susceptible to be 
SUMOylated, a post-translational event that reinforce the repression exerted by 
the R domain. The C (or transactivation) domain contains the amino acids that 
are phosphorylated by MAP kinases. Among these residues, phosphorylation of 
Serine 383 and Serine 389 is a crucial event to activate Elk-1-mediated 
transcription. The two domains depicted in green are involved in the binding of 
Elk-1 to activated MAP kinases. The D (or DEJL) domain is responsible for the 
binding of Elk-1 to activated MAP kinases of the ERK, JNK, and p38 subtypes. 
The DEF (or FXFP) domain is more specific since it is only required for the 
binding of Elk-1 to activated ERK. The NES and NLS motifs are involved in 
nuclear export and import of Elk-1, respectively.www.frontiersin.org  March 2011  | Volume 5  | Article 35  |  3
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Another repression mechanism involves the recruitment of co-
repressor complexes, many of them containing histone deacetylase 
activities (HDACs), which leads to compaction of the chroma-
tin at the level of promoters. One example is the mSin3A–HDAC 
complex, which binds to the N-terminal transcriptional repression 
domain of Elk-1 (Yang et al., 2001). This recruitment is delayed fol-
lowing EGF stimulation and corresponds kinetically to the shut-off 
of target promoters. Activation of the ERK pathway, and specifically 
phosphorylation of Elk-1 at Serine 383, in vivo or in vitro, evokes 
an enhanced binding of the mSin3A–HDAC complex, and hence 
histone deacetylation and chromatin compaction. Thus, Elk-1 rep-
resents a key element that can act sequentially as an activator and 
then a repressor of c-fos transcription.
The functionally active Elk-1 is also regulated by SUMOylation. 
Yang et al. (2002) described the R motif, a novel class of repres-
sion domain of Elk-1 that is located upstream the transactivation 
domain (Figure 1). This domain maintains Elk-1 in an inactive 
state prior to its activation by ERKs. Elk-1 contains three potential 
SUMOylation sites, the Lysines 230, 249, and 254 lying within the R 
motif. In basal conditions, Elk-1 is SUMOylated and inactive (Yang 
et al., 2003). SUMOylated Elk-1 recruits HDAC to the c-fos and 
egr-1 promoters and evokes their repression (Yang and Sharrocks, 
2004). The repression induced by SUMOylation of Elk-1, is reversed 
by activation of ERK, which causes SUMO and HDAC release. In 
the derepression process, the SUMO E3 ligase PIASxα, plays a key 
role in promoting SUMO loss of Elk-1. This PIASxα-mediated 
coactivation of Elk-1 depends on the binding of PIASxα to Elk-1, 
independently of the E3 activity of PIASxα (Yang and Sharrocks, 
2005). PIASxα also reduces the recruitment of HDAC-2 to the c-fos 
promoter, leading to increased histone H4 acetylation and conse-
quent transactivation of this IEG. The activity of PIASxα toward 
HDAC-2 removal is abolished upon activation of the stress-acti-
vated MAPK pathways, despite Elk-1 phosphorylation (Yang and 
Sharrocks, 2006). Finally, Elk-1 can be ubiquitylated in vitro, and 
hence degraded by the proteasomal machinery (Fuchs et al., 1997).
sub-cEllular distribution and rEgulation of Elk-1 
functions in nEuronal cElls
ExprEssion of Elk-1 in thE cns
A strong expression of Elk-1 mRNA in the brain of humans and 
rodents was first described by global analyses (Price et al., 1995). 
A more detailed analysis in the rat brain revealed a widespread 
expression in most brain regions, within neuronal and not glial cell 
types (Sgambato et al., 1998a). Elk-1 is restricted to the nucleus in 
non-neuronal cells (Janknecht et al., 1994; Pingoud et al., 1994), 
a result expected for a transcription factor, but expressed in both 
cytoplasmic and neuritic compartments in addition to the nucleus 
in mature neurons (Sgambato et al., 1998a; Vanhoutte et al., 2001). 
This work also led us to characterize of a neuron-specific isoform 
of Elk-1, named sElk-1, the expression of which is restricted to 
the nucleus. sElk-1 arises from an internal translation start site in 
the Elk-1 sequence, which generates a protein lacking the first 54 
amino acids of the Elk-1 DBD. This truncated isoform of Elk-1 
antagonizes Elk-1-mediated transactivation of SRE and promotes 
neuronal differentiation. The strictly nuclear expression of sElk-1 is 
due to deletion of a NES that was identified within the Ets domain 
(Vanhoutte et al., 2001).
mediator. CBP directly interacts with Elk-1 in vitro and in vivo. This 
  interaction occurs between the Elk-1 C domain and the N-terminus 
of CBP. However, functional interaction occurs only after signaling-
driven phosphorylation of Elk-1 (Janknecht and Nordheim, 1996). 
The N-terminal domain of Elk-1 can also interact with CBP via its 
bromodomain (Nissen et al., 2001). Like CBP, p300 (a CBP-related 
protein) acts like a coactivator in complexes that contain Elk-1 (Li 
et al., 2003). Both CBP and p300 possess an intrinsic histone acetyl-
transferase (HAT) activity or associate with HATs that acetylate 
core histones and relieve repression of transcription through chro-
matin decompaction. Stimulation of HAT activity mediated by 
Elk-1 recruitment is particularly relevant for the c-fos promoter 
since analysis of its chromatin structure revealed a nucleosome 
positioned nearby the SRE site (Herrera et al., 1997). The role of 
Elk-1 in histone acetylation at the c-fos promoter was also studied 
in the context of cortical neurons treated with nerve growth fac-
tor. The increase of Elk-1 phosphorylation and c-fos induction is 
induced by poly-ADP-ribosylated PARP-1, which mediates acetyla-
tion of core histone H4 (Cohen-Armon et al., 2007). A molecular 
bridge between Elk-1 and RNA polymerase II is the Srb mediator 
complex, which plays a role in Elk-1-dependent gene transacti-
vation (Boyer et al., 1999). The local nucleosomal structure also 
facilitates the recruitment of a second transcription factor, the 
nuclear factor I (also known as NF1, NF-1, or CTF, for CAAT box 
transcription factor), which induces the recruitment of the basal 
transcriptional machinery components TFIIB and RNA polymer-
ase II to the c-fos promoter after MAP kinase activation induced 
by phorbol 12-myristate 13-acetate (PMA; O’Donnell et al., 2008; 
White and Sharrocks, 2010). Recently, it was shown that ERK and 
mitogen- and stress-activated kinase (MSK), a kinase for histone 
H3 downstream ERK, is recruited to the SRE promoter complex 
in vitro and in vivo (Zhang et al., 2008). Their recruitment in vitro 
correlates with Elk-1 binding to activated ERK via its DEJL domain. 
Of interest, the recruitment of both ERK and MSK to the DNA 
promoter region is stimulated in vivo by mitogens, and correlates 
with histone H3 phosphorylation. These events are impaired by 
Elk-1 knockdown, thus clearly implicating Elk-1 as a molecular 
partner for the recruitment of MSK at vicinity of nucleosomes in 
DNA promoter regions.
In conclusion, Elk-1 phosphorylation plays a dual role in gene 
regulations, by promoting chromatin remodeling through histone 
acetylation and phosphorylation, and via the recruitment of coac-
tivators of the basal transcriptional machinery.
transcriptional rEprEssion by Elk-1 dEphosphorylation and 
sumoylation
Elk-1 activity depends on the equilibrium between kinases and 
phosphatases. Calcineurin (PP2B) is the major phosphatase of 
Elk-1 identified suggesting an important role of nuclear calcium 
in Elk-1 dephosphorylation (Sugimoto et al., 1997; Tian and Karin, 
1999). Consequently, Cyclosporin A, a PP2B inhibitor, blocks Elk-1 
dephosphorylation in vitro and enhances Serine 383 phosphoryla-
tion (Tian and Karin, 1999).The temporal window in which PP2B is 
active for Elk-1 dephosphorylation has not been investigated so far. 
However, given the transient phosphorylation of Elk-1 in response 
to mitogenic stimuli, one can speculate that kinase activity precedes 
phosphatase-mediated effects on Serine 383 phosphorylation state.Frontiers in Neuroscience  | Neurogenomics    March 2011  | Volume 5  | Article 35  |  4
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activates the ERK/Elk-1 module (Demir et al., 2009). In a follow up 
study, we clarified some of the molecular mechanisms involved in the 
trafficking of activated ERK and Elk-1 proteins from distal neurites 
toward the nucleus in vitro. This retrograde trafficking induced by 
glutamate involves a recruitment of activated ERK and Elk-1 to mac-
romolecular complexes comprising markers of clathrin-dependent 
endocytosis, originating, at least in part, from the endocytosis of 
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptors (Trifilieff et al., 2009).
Thus, by triggering its nuclear translocation, phosphorylation of 
Elk-1 on Serine 383 and Serine 389 is likely to disrupt Elk-1 bind-
ing to microtubules and mitochondria and orients Elk-1 toward 
transcriptional properties at the SRE promoter regions.
Conversely, SUMOylation of lysine residues lying within the R 
domain of Elk-1 also prompts the export of Elk-1 from the nucleus 
toward the cytoplasm (Salinas et al., 2004). The physiological and/
or pathological stimuli that regulate the SUMO pathway in neu-
rons are not yet defined. Nevertheless, by homology with their 
contrasting roles in transactivation or repression of transcription 
in non-neuronal cells (Yang et al., 2003), phosphorylation and 
SUMOylation seems to exert opposing roles on Elk-1 trafficking 
between the cytoplasm and the nucleus in neuronal cell types. 
Another residue, Threonine 417 is phosphorylated in neuronal 
cells by a still unknown kinase. When mutated on this residue, Elk-1 
overexpression in the cytoplasm is not toxic anymore in cultured 
hippocampal neurons. Interestingly, increased cytoplasmic phos-
phorylation of Threonine 417 is observed in various brain tissues 
from patients with neurodegenerative diseases (Sharma et al., 2010).
Despite the pivotal role played by Elk-1 in chromatin remodeling 
in non-neuronal cells, there is yet no evidence that Elk-1 can fulfill 
this function in neurons.
parsing nuclEar functions of Elk-1 in nEuronal cElls
The complexity of Elk-1 localization and functions within neuro-
nal cells prompted us to design new molecular approaches for spe-
cific impairment of ERK-dependent phosphorylation and nuclear 
translocation. We used the TAT–DEF–Elk-1 peptide that selectively 
impairs Elk-1 phosphorylation by ERK on Serine 383 and Serine 389 
residues. Importantly, the specific inhibition of Elk-1 phosphoryla-
tion, and subsequent nuclear translocation, was associated with a 
defect in glutamate-induced expression of IEGs bearing SRE site(s) 
on their promoter, such as c-fos, junB, and zif 268 (Lavaur et al., 2007).
Consistent with the known role of Elk-1 as a transcriptional acti-
vation of the srf gene (Kasza et al., 2005), chronic blockade of Elk-1 
phosphorylation was associated with a decrease of SRF expression 
in neurons (Lavaur et al., 2007). This was particularly interesting 
given that SRF was shown to behave as a sensor of cytoskeleton 
actin dynamics (Knoll and Nordheim, 2009). Indeed, conditional 
srf knock-out mice in the forebrain present a reduced expression 
level of actin, an impairment of axonal guidance and defects in 
growth cones morphology (Knoll et al., 2006). Interestingly, when 
Elk-1 phosphorylation is inhibited, SRF and actin levels are down 
regulated and growth cone collapse occurs (Lavaur et al., 2007). 
Thus, inhibition of Elk-1 phosphorylation by ERK or knock out 
of the srf gene leads to somewhat overlapping phenotypes. This is 
consistent with SRF being a critical cofactor for Elk-1 transcrip-
tional activity at SRE sites (Shaw et al., 1989). However, Elk-1 is 
Since then, the presence of Elk-1 in the cytoplasm of neurons 
or neuroblastomas was confirmed, but Elk-1 functions in this par-
ticular compartment remain elusive. Studies form Eberwine and 
colleagues demonstrated that Elk-1 binds to the mitochondrial 
permeability transition pore (PTP) complex, an interaction being 
reinforced in experimental conditions triggering apoptosis of corti-
cal neurons (Barrett et al., 2006a). They showed that overexpres-
sion of Elk-1 in primary neurons decreases cell viability, whereas 
Elk-1 siRNA-mediated knockdown increases cell survival. This 
decrease in viability induced by Elk-1 overexpression is blocked 
with application of a PTP inhibitor. These results suggested that one 
extranuclear function for Elk-1 was pro-apoptotic. By means of a 
region-directed phototransfection of Elk-1 mRNA, the same group 
made the interesting observation that overexpression of Elk-1 in 
distal dendrites was toxic whereas its presence, when restricted to 
the cell body, did not trigger neuronal death (Barrett et al., 2006b). 
Recently, a direct interaction of Elk-1 with tubulin has been dem-
onstrated (Demir et al., 2009), however the physiological role of 
this binding to neuronal microtubules is not yet defined.
rEgulation of Elk-1 cyto-nuclEar shuttling by translational 
modifications
Although mature neurons are post-mitotic cells, ERKs are strongly 
expressed and activated by multiple extracellular stimuli, including 
neurotransmitters, neuromodulators, and neurotrophic factors (for 
review Valjent et al., 2001a; Thomas and Huganir, 2004). A large body 
of evidence implicates this signaling pathway, along with downstream 
substrates, in learning and memory. Yet, there is no direct evidence 
implicating Elk-1 in these processes. An ERK-dependent Serine 383 
phosphorylation of Elk-1 has been found in nuclear, somatic, and 
dendritic compartments upon electrical stimulation of the cortico-
striatal pathway in vivo (Sgambato et al., 1998a,b). In this model sys-
tem, ERKs activation is involved in the induction of zif268, c-fos, and 
mkp-1 (MAP kinase phosphatase 1). ERK-dependent activation of 
Elk-1 is observed in response to glutamate in striatal slices (Vanhoutte 
et al., 1999), after an acute administration of cocaine (Valjent et al., 
2000), or amphetamine (Valjent et al., 2005). ERK-induced Elk-1 
phosphorylation is also detectable in hippocampal neurons after 
induction of long-term potentiation (LTP; Davis et al., 2000) or dur-
ing contextual fear conditioning (Sananbenesi et al., 2002). The find-
ing that Elk-1 is activated in the cytoplasm suggested that it may have 
a local role and/or translocate to the nucleus upon phosphorylation 
by ERKs. Using total Elk-1 immunolabeling Caboche and colleagues 
found that indeed Elk-1 translocates to the nucleus upon activation 
by cocaine in vivo, or glutamate in vitro (Lavaur et al., 2007). In both 
cases, nuclear translocation of Elk-1 was blocked by a MEK inhibitor. 
Furthermore, using a cell-penetrating peptide that specifically inter-
feres with the DEF docking domain of Elk-1 (TAT–DEF–Elk-1), and 
as such blocks Elk-1 phosphorylation induced by ERKs, we observed 
retention of Elk-1 within the cytoplasm. The TAT–DEF–Elk-1 pep-
tide does not interfere with ERK activity toward other substrates, such 
as MSK-1. This approach, combined with site-directed mutagenesis 
in the Elk-1 Serine 383 and Serine 389 phosphorylation sites, dem-
onstrated that Elk-1 translocation from the cytoplasm to the nucleus 
is tightly linked to its activation by ERKs (Lavaur et al., 2007). The 
nuclear translocation of activated Elk-1 was further confirmed in 
neuroblastoma cells treated with high concentration of serum that www.frontiersin.org  March 2011  | Volume 5  | Article 35  |  5
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phenotype when compared to wild-type littermate (Cesari et al., 
2004). Within the brain, no alteration in the proteomic display was 
found, but a modest decrease in c-Fos and Zif268 expression was 
observed in the hippocampus and cortex after kainate-induced 
seizure. No deficits in the immunological response were found in 
these mice. Our studies, using elk-1 knock-out mice, showed no 
gross alteration of brain histology and no modification of cocaine-
induced gene regulation in the striatum (personal observation). As 
suggested by Nordheim and colleagues (Cesari et al., 2004), this 
mild phenotype could be attributed to a functional redundancy 
between Elk-1 and other TCF members.
An ERK-dependent Serine 383 and Serine 389 phosphorylation 
of Elk-1 has been observed in various models of synaptic plasticity. 
LTP is a possible cellular mechanism for information storage. The 
ERK signaling pathway is critical for this synaptic plasticity (Sweatt, 
2004), probably because it controls the induction of some IEGs, 
including zif268 (Davis et al., 2000). In vivo, zif268 mRNAs are 
induced within the dentate gyrus (DG) immediately after a high fre-
quency tetanus of the perforant path. In this model, a concomitant 
hyperphosphorylation of ERK, along with Elk-1 and the transcrip-
tion factor CREB, can be found in the same region. Pharmacological 
blockade of MEK inhibits Elk-1 and CREB phosphorylation as well 
as zif268 mRNA induction and LTP (Davis et al., 2000). This study 
provided the first in vivo evidence that ERK activation is critical for 
LTP. Afterward, the essential role of Zif268 in LTP was established. 
Mice deficient for Zif268 show a deficit in late, but not early, LTP and 
long-term memory (Jones et al., 2001). Similarly, Thiels et al. (2002) 
showed a robust increase in nuclear ERK and Elk-1 phosphor-
ylation after electrical NMDA-dependent long-term depression 
also able to regulate transcription of defined set of genes in a SRF-
independent fashion (Boros et al., 2009a,b). This raises the ques-
tions as to whether phenotypes induced by Elk-1 inhibition are due 
to the associated down-regulation of SRF and/or to mechanisms 
involving Elk-1 activation independently of SRF.
Altogether these data clearly indicates that post-translational 
modifications of Elk-1 play a crucial role in the control of both Elk-1 
cytoplasm-to-nucleus shuttling and Elk-1 functions (Figure 2). In 
PC12 cells, SUMO conjugation to Elk-1 increases its shuttling to 
cytoplasmic compartments, and inhibits spontaneous neuronal 
differentiation induced by wild-type Elk-1 (Salinas et al., 2004). 
Within the cytoplasm, Elk-1 tends to be toxic, at least when it is 
associated with the mitochondrial PTP or expressed in the distal 
dendrites (Barrett et al., 2006a,b). As opposed to these deleterious 
effects of Elk-1 in the cytoplasm, ERK-induced phosphorylation 
of Elk-1 on Serine 383 and Serine 389 forces Elk-1 translocation 
to the nucleus, where it plays an important role in SRE-dependent 
transcription, promotes neuronal differentiation, and regulates the 
cytoskeleton dynamics (Lavaur et al., 2007). The pivotal role played 
by Elk-1 in IEGs induction, downstream of ERK activation raises 
the question as to whether Elk-1 phosphorylation is involved in 
synaptic plasticity, learning, and long-term behavioral adaptations.
Elk-1, a molEcular partnEr of Erk in synaptic 
plasticity and complEx bEhaviors
Elk-1 phosphorylation and nEuronal plasticity
Elk-1 is a target of ERK but also of JNK and p38 MAPK, which are all 
involved in diverse physiopathological forms of neuronal plasticity. 
Mice deficient for the elk-1 gene present a mild alteration in their 
FiguRE 2 | Synthetic view of the impact of Elk-1 post-translational modifications on its cytoplasm-to-nucleus trafficking and functions in neurons (see 
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suggest that Elk-1 interaction with DNA per se is not   necessary 
for spatial memory formation. However, a specific role of Elk-1 in 
such memory process cannot be totally ruled out. In fact, phos-
phorylation of Elk-1 by ERK can trigger multiple molecular events 
that do not specifically require binding of Elk-1 to DNA, including 
recruitment of MSK-1 and subsequent phosphorylation of his-
tones (Zhang et al., 2008), increased binding to SRF, or functional 
interactions with CBP, and recruitment of the basal transcriptional 
machinery. Whether these molecular events are disrupted using the 
decoy oligonucleotides directed against binding of Elk-1 to DNA 
remains to be established. In conclusion, in the absence of specific 
pharmacological inhibitors, or genetic models aimed at specifically 
blunting Elk-1 Serine 383 phosphorylation, we cannot conclude 
about the causative link between this phosphorylation event, long-
term neuronal plasticity and learning.
A cross-talk between ERK and PI3K/SGK1 (serum- and gluco-
corticoid-inducible kinase 1) signaling pathways for the regulation 
of Elk-1 transcriptional activity arises from a recent work. Using 
the Morris water maze and microinjecting the negative mutant of 
SGK1 in the hippocampal CA1 of rats before the training sessions, 
the authors found an impairment of mRNAs encoding CREB and 
phosphorylation of SRF, along with an impaired induction of Zif268 
and memory formation (Tyan et al., 2008). Interestingly, in vitro 
results revealed that active SGK1 may negatively regulate Elk-1 tran-
scriptional activity through phosphorylation of Elk-1 at Serine 159 
and Threonine 160, which interrupts Elk-1 binding to SRF. Thus, 
future work will be required to shed light on the relevance of these 
findings in the context of long-term memory formation.
Elk-1 activation and drugs of abusE
The ERK pathway is a central actor in addiction (Lu et al., 2006). 
Our group pioneered the observation that ERK is activated upon 
acute cocaine administration in mice (Valjent et al., 2000). We 
found a strong and transient hyperphosphorylation of ERK and 
Elk-1 in the striatum of mice after an acute cocaine administration 
(Valjent et al., 2000). Pretreatment with SL327, a MEK inhibitor that 
can cross the blood–brain barrier, abolished Elk-1 phosphorylation, 
the induction of Zif268 and c-Fos, and the establishment of con-
ditioned place preference (CPP) induced by cocaine. These results 
were recently confirmed in rats (Jenab et al., 2005; Sun et al., 2007).
Then, a common feature of drugs of abuse was shown, i.e., a 
transient activation of ERK in the striatum and extended amygdala 
(Valjent et al., 2004). Thus, nicotine, ∆9-THC (the psychoactive 
molecule of cannabis), morphine, and amphetamine were shown to 
activate ERK in these brain areas, in a dopamine-dependent manner 
(Valjent et al., 2004). Increased phosphorylation of Elk-1 was fur-
ther demonstrated in the striatum of mice upon ∆9-THC (Valjent 
et al., 2001a,b) and amphetamine (Choe et al., 2002) treatments, 
and in the hippocampal CA1 area after acute nicotine administra-
tion (Nuutinen et al., 2007). Acute ethanol exposure triggered Elk-1 
hyperphosphorylation in subregions of the amygdala (Pandey et al., 
2008). To date, in vivo activation of Elk-1 by morphine has not 
been investigated. However, a recent study used small interfering 
RNAs for Elk-1 and CREB in HEK cells expressing the rat μ-opioid 
receptor (Ligeza et al., 2008). Silencing of Elk-1 and CREB activity 
diminished the cellular responses to withdrawal signals and chronic 
opioid treatment in this in vitro system.
(LTD) induction in the hippocampal CA1 area. The MEK inhibitor 
SL327 totally abolished Elk-1 hyperphosphorylation and NMDA-
dependent LTD, thus confirming that Elk-1 activation depends on 
ERK and is associated with LTD in vivo. In accordance with these 
results, Lindecke et al. (2006) reported a strong hyperphosphoryla-
tion of Elk-1 after LTD induced by a stimulation of metabotropic 
glutamate receptors (mGluR) on mouse organotypic hippocampal 
slices. Interestingly, mGluR-induced LTD at CA3–CA1 synapses was 
previously described as dependent on p38 activity in mouse hip-
pocampal slices (Bolshakov et al., 2000). Future studies are needed 
to further delineate a possible involvement of p38/Elk-1 module 
in mGluR-induced hippocampal LTD.
Elk-1 phosphorylation in modEls of lEarning
In light of the growing evidence that MAPKs are involved in the 
formation of long-term memory, Berman et al. (1998) showed 
that aversive taste-learning experience-induced transient phos-
phorylation of ERK, JNK, and Elk-1 (but not p38 nor AKT) in 
the insular cortex (IC). Microinfusion of the MEK inhibitor in 
the  IC  totally  abrogates  Elk-1  phosphorylation  and  partially 
impairs the acquisition of the conditioned-taste aversion. In a 
further study, local microinjection of pharmacological antagonists 
revealed that taste-induced Elk-1 activation in the IC depends 
on glutamatergic, dopaminergic, and acetylcholinergic receptors 
stimulation (Berman, 2003). Altogether, these results indicates 
that taste-dependent Elk-1 phosphorylation in the IC depends 
on ERK, which contributes to the acquisition of the long-term 
taste memory. Similar results were obtained in the visual cortex, 
where Elk-1 is transiently phosphorylated by a visual stimulation 
applied after a period of dark rearing (Kaminska et al., 1999). 
ERK, but not JNK activation, was temporally matched to the 
onset of Elk-1 phosphorylation, whereas p38 phosphorylation 
was unaltered in this paradigm. One-trial avoidance learning is 
also associated with a specific increase in the phosphorylation 
of ERK, Elk-1, CREB, and c-Fos expression in the hippocampus 
(Cammarota et al., 2000). Microinfusion of a NMDA receptor 
antagonist in the hippocampal CA1 area impairs the activation 
of the ERK signaling cascade as well as the acquisition of one-
trial avoidance learning. A coincident hyperphosphorylation of 
ERK, Elk-1, and RSK-1 is also observed in the CA3 hippocampal 
subfield and the DG 30 min after context-dependent fear condi-
tioning (Sananbenesi et al., 2002).
Elk-1 has been associated with food aversion conditioned reflex, 
which depends on serotonin in edible snail (Grinkevich et al., 2004). 
The authors used two different models of serotonin-depleted ani-
mals displaying altered abilities to develop the defense reflex. In 
both models, experience-induced ERK and Elk-1 phosphorylation 
are significantly altered as compared to controls. Altogether, these 
results suggest that an alteration of serotonin metabolism leads to 
the disruption of ERK and Elk-1 activity possibly accounting for 
the edible snail inability to develop defense reflex.
In order to elucidate the role of Elk-1 interaction with DNA, 
decoy oligonucleotides were used to block either Elk-1 or SRF bind-
ing to DNA. These oligonucleotides were microinjected in the hip-
pocampus of rats before being trained to the Morris water maze 
(Dash et al., 2005). Interestingly, sequestration of SRF, but not Elk-1, 
is sufficient to disrupt long-term spatial memory. These results www.frontiersin.org  March 2011  | Volume 5  | Article 35  |  7
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Elk-1, and PS1. Future investigations should aim at deciphering if 
Aβ derepresses PS1 expression by inhibiting Elk-1 activity in AD 
and/or FAD pathogenesis.
Huntington’s disease
Huntington’s disease (HD) is a neurodegenerative disorder due 
to abnormal polyglutamine expansion in the N-terminal region 
of huntingtin (Htt) protein. This expansion causes protein aggre-
gation, transcriptional dysregulations, neuronal dysfunction, and 
finally death. ERK, Elk-1, and CREB were reported to be hyper-
phosphorylated in the striatum of R6/2 transgenic, a mouse model 
of HD (Roze et al., 2008). However, transcriptional activity at the 
c-fos promoter was impaired, probably because of MSK-1 expres-
sion deficiency in this mouse model. Interestingly, deficiency of 
MSK-1 expression was also found in the striatum, but not cor-
tex, of HD post-mortem brain patients. Histone H3 and MSK-1 
phosphorylation, along with transcriptional dysregulations, may 
account for striatal degeneration in R6/2 mice. Restoring MSK-1 
expression reversed neuronal dysfunctions induced by expanded 
Htt, in vitro (Roze et al., 2008). Given the key role of Elk-1 in the 
recruitment of MSK-1 at the vicinity of histone H3 (Zhang et al., 
2008), it would be interesting to analyze a possible synergy between 
Elk-1 and MSK-1 in neuronal protection in HD.
Synucleinopathies
α-Synuclein forms aggregate in neurons in Parkinson’s disease (PD) 
and mainly in oligodendrocytes in multiple system atrophy (MSA). 
α-Synuclein interacts indirectly with Elk-1 via ERK, and prominently 
attenuates Elk-1 phosphorylation on Serine 383 along with c-Fos 
induction in response to EGF in Neuro2A cells (Iwata et al., 2001). 
Nevertheless, no causative link between this phosphorylation event 
and the degenerative process has been described so far in PD or MSA.
The accumulation of a cytoplasmic and toxic form of Elk-1 has 
been observed in post-mortem brain from patients affected with 
each of the three neurodegenerative diseases mentioned above. An 
increased cytoplasmic phosphorylation of Elk-1 on Threonine 417 
was found to colocalize with inclusions in PD (Lewy body), AD, 
and HD (Sharma et al., 2010).
Down syndrome
Age-dependent alterations of ERK activity were observed in brains 
from Ts65Dn mice, a transgenic mice model of Down syndrome 
(DS; Gardiner, 2003). A decrease of calcineurin activity, the major 
phosphatase for Elk-1, was also observed in the fetal DS brain 
and aged Ts65Dn mice. Expression of SUMO3 that inhibits Elk-1 
activity by triggering its sumoylation in vitro, was increased in the 
hippocampus of the adult DS patient (Gardiner, 2006). DS is thus 
associated with alterations of ERK, calcineurin, and SUMO path-
ways, which all converge and act antagonistically on Elk-1 activity. 
This raises questions as to whether Elk-1 functions might be altered 
in rodent models of DS and, if so, what are the potential behavioral 
consequences of such deregulation.
Depression
Extracellular-signal regulated kinase mRNA and protein levels were 
found to be decreased in the prefrontal cortex and hippocampus, 
but not the cerebellum, in post-mortem brains of depressed suicide 
Besides Elk-1, ERK controls the phosphorylation levels of the 
transcription factor CREB, which plays an important role in the 
expression of genes involved in synaptic plasticity and drug addic-
tion (Carlezon Jr. et al., 1998; for review, see Nestler, 2004). CREB 
phosphorylation at Serine 133 is not catalyzed directly by ERK 
but by protein kinases activated by ERK, including two isoforms 
of mitogen-activated protein kinase-activated protein kinase 1 
(MAPK-APK1; also called ribosome S6 kinases, RSKs; De Cesare 
et al., 1998; Xing et al., 1998) and mitogen- and stress-activated 
protein kinases (MSKs; Deak et al., 1998; Arthur and Cohen, 2000). 
Activation of MSKs is also implicated in histone H3 phosphoryla-
tion (Soloaga et al., 2003) and thus in chromatin reorganization 
(Nowak and Corces, 2004).
Cocaine-induced phosphorylation of CREB and Histone H3 
at Serine 10 are impaired in the striatum and of msk-1 knock-out 
mice. In these mice, the induction by cocaine of c-Fos and Dyn but 
not Zif268 expression is altered (Brami-Cherrier et al., 2005). These 
mice display a partial decrease of locomotor sensitization, with a 
slight increase of CPP. This study demonstrates that alterations of 
the ERK/MSK-1/CREB signaling module only partially recapitu-
late the molecular and behavioral alterations observed with SL327, 
which abrogates both locomotor sensitization and CPP induced by 
cocaine (Valjent et al., 2000, 2006). Because MSK-1 cannot target 
some important SRE-driven IEGs (including Zif268) induced by 
cocaine, we suspect that an ERK/Elk-1 module may be involved in 
some important molecular and behavioral adaptations to cocaine, 
and by extension most drugs of abuse.
The ERK pathway is also critical for the retrieval (or expression) of 
a previously established CPP, in the absence of drug administration. 
Hyperphosphorylation of ERK and Elk-1 in the nucleus accumbens 
(NAcc) is associated with the expression of methamphetamine- and 
cocaine-induced CPP (Mizoguchi et al., 2004; Miller and Marshall, 
2005). Local inhibition of ERK blocks the expression these behav-
iors. MEK inhibition during memory retrieval resulted in a long 
lasting amnesic effect (at least 2 weeks post-infusion) indicating 
that ERK is required for both the establishment and retrieval of 
memory. Analyzing the specific role of Elk-1 phosphorylation on 
Serine 383 in these two paradigms might be critical.
phosphorylation of Elk-1 in pathophysiological conditions
As illustrated in this section, Elk-1 phosphorylation has been shown 
to be modulated in various CNS diseases.
Alzheimer’s disease
Accumulation of amyloid-β (Aβ) peptides initiates and/or con-
tributes to Alzheimer’s disease (AD). Tong et al. (2004) showed 
that sublethal concentrations of Aβ interfere with BDNF-induced 
activation of Elk-1 in cultured cortical neurons and results in an 
altered SRE-driven gene regulation, which is likely to account 
for increased neuronal vulnerability. Pastorcic and Das (2003) 
defined Elk-1 as a potent repressor of transcription of the prese-
nilin 1 gene (PS1) encoding for a protein required for the final 
step of the sequential proteolytic processing of amyloid precursor 
protein (APP), which produces highly amyloidogenic variants of 
Aβ (Aβ42/43 polypeptide). PS1 is genetically linked to the major-
ity of cases of early-onset of familial Alzheimer’s disease (FAD). 
Collectively, these data highlight the intriguing link connecting Aβ, Frontiers in Neuroscience  | Neurogenomics    March 2011  | Volume 5  | Article 35  |  8
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associated with altered ERK signaling. Future work will be needed 
to determine a potential involvement of Elk-1 in the pathophysiol-
ogy of depression.
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or mnesic processes.
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